Fiscal Year 2023 The company raises full-year outlook to reflect third quarter performance: • Consolidated net sales growth of about 5.5%. Excluding divestitures3 , consolidated net sales growth of about 6.5%. Based on current exchange rates, the company expects a headwind of about $4.1 billion for the year. • Walmart U.S. comp sales growth, excluding fuel, of about 5.5%. • Consolidated adjusted operating income decline of 6.5% to 7.5%, which improved from the company’s prior guidance of a decline of 9.0% to 11.0% and reflects better performance in the third quarter. Excluding divestitures3 , consolidated adjusted operating income decline of 5.5% to 6.5%. • Adjusted earnings per share decline of 6.0% to 7.0%. Excluding divestitures3 , adjusted earnings per share decline of 5.0% to 6.0%.
Lexaria’s Human Nicotine Study Nearing Start Date
https://www.accesswire.com/708333/Lexarias-Human-Nicotine-Study-Nearing-Start-Date